Urine Electrolyte Excretion in a Hypertensive Population of East Africans by Dobrovolskaite, Aiste
Western Kentucky University
TopSCHOLAR®
Masters Theses & Specialist Projects Graduate School
Spring 2017
Urine Electrolyte Excretion in a Hypertensive
Population of East Africans
Aiste Dobrovolskaite
Western Kentucky University, aiste.dobrovolskaite504@topper.wku.edu
Follow this and additional works at: http://digitalcommons.wku.edu/theses
Part of the International Public Health Commons
This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by
an authorized administrator of TopSCHOLAR®. For more information, please contact topscholar@wku.edu.
Recommended Citation




















The Faculty of the Department of Biology 
Western Kentucky University 












In Partial Fulfillment 
Of the Requirements for the Degree 



















I will forever be thankful to my primary advisor, Dr. Nancy Rice, for choosing me 
as a graduate student and assigning me a project that changed my life. I would like to 
thank Dr. Rice for being an amazing mentor inside and outside the boundaries of the 
university, for sharing her experience, providing her support throughout the process, and 
especially for introducing me to Kenya which was the most amazing experience of my 
graduate career.   
I would like to thank my committee members, Dr. Sigrid Jacobshagen and         
Dr. Kenneth Crawford, who provided their support and feedback on my thesis project.     
I would like to thank Jessica Dunnegan who always had answers in a time of crisis.  
I would like to thank all graduate students who surrounded me these past two 
years for sharing their experience and knowledge. I am especially thankful to Meghan 
Parsley for being a great friend, helping me whenever I needed, and for our puzzle nights 
that were a great escape from all the stress. Also, a special thanks to my lab peer Jesse 
Nugent, who I got to share great times in the laboratory and classes. 
I could not have done this without tremendous support from my parents, my 
sister, and my boyfriend, Richard. These people never had a doubt that I could 
accomplish everything I started, even when I was doubting myself. I am grateful for all 
the times when they listened to my detailed explanations of my project while having no 
clue what I was talking about, yet never interrupting.  
Lastly, this project would not been doable without funding from a Western 
Kentucky Student Research Grant and the willingness of lovely people of Kasigau who 






INTRODUCTION ............................................................................................................. 1 
          Global perspective of Noncommunicable Diseases  ................................................ 1 
          Cardiovascular Diseases  ......................................................................................... 3 
          Hypertension ............................................................................................................ 4 
          Hypertension in Kenya ............................................................................................ 6 
          Physiology and Renal Blood Pressure ..................................................................... 9 
          Salt-sensitive Hypertension and the Renin-Angiotensin System  .......................... 10 
          Salt-sensitivity in a Hypertensive Cohort in Kenya ............................................... 12 
METHOD AND MATERIALS ....................................................................................... 15 
          Ethics Review and Compliance  ............................................................................ 15 
          Study Participants .................................................................................................. 15 
          Urine Stability Tests .............................................................................................. 15 
          Urine Sampling Protocols ...................................................................................... 16 
          Anthropometric Data Collection ............................................................................ 17 
          Urine Sample Collection and Analysis .................................................................. 18 
          Statistical Analysis ................................................................................................. 19 
RESULTS  ....................................................................................................................... 20 
          Urine Stability Tests  ............................................................................................. 20 
          Demographic Results  ............................................................................................ 22 
          Electrolyte Excretion Comparison by Hypertensive Category  ............................. 24 
          Electrolyte Excretion Comparison by Age  ........................................................... 29 
          Linear Regression Analysis – Sodium  .................................................................. 33 
          Linear Regression Analysis – Potassium and Chloride ......................................... 37 
          Electrolyte Excretion Comparison by BMI  .......................................................... 39 
DISCUSSION  ................................................................................................................. 45 
REFERENCES  ............................................................................................................... 51 
APPENDIX  ..................................................................................................................... 57 





LIST OF FIGURES 
 
Figure 1.  Deaths due to NCDs. ......................................................................................... 2 
Figure 2.  Prevalence of hypertension in age-standardized populations for males and              
females.  females ................................................................................................................ 5 
Figure 3.  Map of Kenya and Kasigau. .............................................................................. 8 
Figure 4.  Renin-Angiotensin System. ............................................................................. 11 
Figure 5.  Mean electrolyte excretion for males and females in the sudy population. .... 23 
Figure 6.  Electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for different 
hyperten  hypertensive stages. ......................................................................................... 26 
Figure 7.  Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 
different  different hypertensive stages for females (a) and males (b). ........................... 28 
Figure 8.  Mean systolic BP values of males and females, divided by age ..................... 31 
Figure 9.  Mean electrolyte values of estimated 24HU Na+, K+ and SU Cl- for males and 
females,   females, divided by age. .................................................................................. 32 
Figure 10. Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic  
SBP (mm  BP (mmHg). ................................................................................................... 34 
Figure 11. Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic   
SBP (mm  BP (mmHg) for females. ................................................................................ 35 
Figure 12. Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic  
SBP (mm  BP in (mmHg) for males. ............................................................................... 36 
Figure 13. Relationship between electrolytes excretion (mmol/L) for estimated 24HU K+ 
blah blah   and SU Cl- vs systolic BP (mmHg). ............................................................... 38 
Figure 14. Mean systolic BP values of males and females divided by BMI ................... 40 
Figure 15. Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 
different   different BMI categories. ................................................................................ 41 
Figure 16. Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 
categories different BMI categories for (a) females and (b) males. ................................ 44 
Figure 17. Cycle of aging, inflammation, and oxidative stress in relationship to 




LIST OF TABLES 
 
Table 1.  SU stability tests in different temperatures (~23 ̊C, 4 ̊C and – 20 ̊C) and different 
timemmj time (0h, 24h, 48h, 72h).. ................................................................................. 21 
Table 2.  Multiple analyzes of one SU sample at ~23 ̊C and 0h after changing K+ 
timemmj electrode... ........................................................................................................ 21 
Table 3.  Characteristics of study population................................................................... 23 
Table 4.  Mean systolic BP and urine electrolyte excretion means for normotensive, pre- 
number   hypertensive and combined hypertensive stage I & II categories .................... 25 
Table 5.  Mean systolic BP and urine electrolyte excretions for overall study population, 
superinf  males and females, divided by age. .................................................................. 30 
Table 6.  Mean systolic BP and urine electrolyte excretion means for underweight, 





URINE ELECTROLYTE EXCRETION IN A HYPERTENSIVE POPULATION OF 
EAST AFRICANS 
 
Aiste Dobrovolskaite               May 2017                     63 Pages 
  
Directed by: Nancy Rice, Sigrid Jacobshagen, Kenneth Crawford 
 
Department of Biology              Western Kentucky University 
 
Chronic noncommunicable diseases (NCDs) are the largest contributor to 
mortality rates worldwide including in low- and middle- income countries (LMICs) 
which already suffer from high rates of infectious disease. Among the four major NCDs 
that cause 38 million deaths annually, cardiovascular disease (CVD) causes 17.5 million 
of these annual deaths.  The primary risk factor of CVD is hypertension.  Kenya, a 
developing country in Sub-Saharan Africa, has a high rate of hypertension with low 
(2.6%) management rates.  Prior research from our lab has identified a population of 
Kenyans with a high prevalence of hypertension that is not statistically correlated with 
typical known risk factors such as obesity, hypercholesterolemia, and behaviors of 
smoking and lack of exercise.  This study investigated the hypothesis that high dietary 
salt consumption and low K+ dietary intake are contributing to the etiology of high blood 
pressure in this community.  To test our hypothesis, two spot urine samples representing 
nocturnal excretions (evening and morning) and blood pressure measurements were 
collected from 135 participants. All samples were analyzed for Na+, K+ and Cl- content 
using the Smartlyte Electrolyte Analyzer.  The average of each spot urine sample was 
extrapolated to an estimated 24-h value by the method of Mills, et al.  The overall 
population mean urine electrolyte excretion values for Na+, K+ and Cl- were 170.6 ± 89.3 
mmol/L, 82.0 ± 54.0 mmol/L, and 87.7 ± 42.1 mmol/L, respectively.  While these values 




are under normal excretion levels for Cl- (110-250mmol/L).  Overall ion excretion was 
higher in females than males, although only K+ values were statistically significant          
(p < 0.05).  Analysis of Na+ and Cl- excretion from individuals stratified by blood 
pressure, revealed significant differences (p < 0.05) between normotensive and 
hypertensive stage I individuals for both electrolytes (57.9 mmol/L vs. 88.9 mmol/L and 
65.5 mmol/L vs. 96.7 mmol/L, respectively).  Overall, these results suggest that our 
sample population consumes dietary salt within a normal range and thus, the observed 







Global perspective of Noncommunicable Diseases 
Noncommunicable diseases (NCDs) are the leading cause of death worldwide, 
with an annual mortality rate of 38 million (World Health Organization (WHO), 2014a).   
Among all NCDs, cardiovascular disease (CVD), cancer, diabetes, and respiratory 
diseases account for 82% of all NCD deaths (WHO, 2014a).   In the past it was thought 
that NCDs mainly occurred in high-income countries, however, currently the highest 
death rate from NCDs (28 million) is seen in low- and middle-income counties (LMIC) 
(Sommer et al., 2015; WHO, 2014a).   Through many advancements in the last few 
centuries such as screening for diseases, clinical practice, improved technology and 
treatment, medicine as well as increased funding for biomedical research, human life 
expectancy has increased above 65 years and older by 22% in the past 50 years 
(Olshansky, 2015).   Notwithstanding the positives of living longer, there are also 
negatives such as accumulating NCDs over a lifetime.   The World Bank defines low-
income countries as those with a Gross National Income (GNI) per capita per year of 
$1,025 or less and lower middle-income countries having GNI per capita between $1,026 
and $4,035 per year (“The World Bank Country and Lending Groups”, 2015).   Fifty one 
percent of all LMICs belong to the continent of Africa where poverty and NCDs collide 





Figure 1.  Deaths due to NCDs.  Age-standardized death rates (per 100,000 
population) for both sexes (2012).  Data source: WHO 2014.  Map Production: Health 
Statistics and Information Systems (HSI). 
 
As a result of the poverty in African countries, there is a lack of access to health 
care and shortages of medication.  Because of such poor health management, people in 
Africa have the highest death rates of concomitant infections and NCDs (BeLeu et al. 
2009).  Since most government funding in these areas is used to fight infectious diseases, 
such as Ebola, human immunodeficiency virus (HIV), dengue and malaria, NCDs do not 
get sufficient resources to address the high number of deaths.  The last decade provided 
evidence that vaccinations for most of the communicable diseases reduced mortality rate 
among children, however, this caused African populations to undergo an epidemiological 
transition (Byass et al., 2014; Bygbjerg, 2012).   
Epidemiological transitions are recognized by a shift from high mortality rates of 
infants and children to a high mortality rates of the elderly.  This transition in developing 
countries is mainly caused by urbanization, development, industrialization and aging of 
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the whole population (Bygbjerg, 2012; Mathenge et al., 2010; Van de Vijver et al., 2013).  
Out of 16 million NCD premature deaths that occur between ages 30 and 70, developing 
countries have the highest mortality rates (85%) (WHO, 2014b).  To deal with this 
modern century problem, the WHO suggests focusing on prevention of NCDs in order to 
prevent chronic health problems that would be significantly more expensive to treat. 
Cardiovascular Diseases 
Out of four major NCDs, CVD has the highest annual mortality rate of 17.5 
million, followed by cancer, respiratory diseases and diabetes with 8.2, 4 and 1.5 million 
respectively (WHO, 2011; WHO, 2014a).  The continent most impacted by CVD is 
Africa, with the death rates for both males and females expected to increase more than 
100% in developing countries by the year 2020 (Kayima et al., 2013; Yach et al., 2004).  
To address this problem, the prevalence of CVD risk factors needs to be determined and 
subsequently managed.  CVD is considered to have two major categories of risk markers: 
modifiable (reversible) and non-modifiable (irreversible) (Van de Vijver et al., 2013).   
Modifiable risk factors include hypertension (also known as high blood pressure 
(BP)), obesity, hyperlipidemia, and environmental exposure, while non-modifiable risk 
markers refer to age, gender, and family history (WHO, 2011).  While some scientists 
argue that race and ethnicity are also contributing factors to CVD, there has not been 
sufficient evidence to support this hypothesis (Kurian & Cardarelli, 2007).  However, 
race and ethnicity are thought to correlate to socioeconomic status, which can influence 
CVD as a risk factor (Kurian & Cardarelli, 2007).  According to the WHO, hypertension 
is identified as the primary risk factor for CVD (WHO, 2013) as well as other NCDs that 
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lead to disability or death worldwide (Lim et al., 2012).   To treat the increase in CVD 
over the next ten years it would cost approximately one trillion dollars if precautionary 
measures are not implemented today (Bloom et al., 2011; Vedanthan et al., 2014).  Thus, 
it is necessary to control and treat high BP now in order to reduce the risk for CVD and 
other NCDs. 
 Hypertension 
In the last four decades, the number of people with hypertension increased from 
594 million to 1.3 billion worldwide with the highest increase in LMIC in both genders, 
(Figure 2) (Zhou et al., 2017).  The number of individuals with elevated BP are 
undeniably rising, and by 2025, worldwide hypertension prevalence is predicted to 
increase by 60%, of which developing countries will have 25% of the global hypertension 
population (Chockalingam et al., 2006; WHO, 2014a).  Adults over 25 years old are 
considered to have hypertension if their systolic BP ≥ 140 mmHg, their diastolic BP ≥ 90 
mmHg, they are taking antihypertensive medication or any combination of the above 








Figure 2.  Prevalence of hypertension in age-standardized populations for males (top) 
and females (bottom) aged 18 years and older.  Data source: WHO.  Map Production: 
Health Statistics and Information Systems (HSI). 
 
Hypertension can be further categorized as primary (essential) hypertension or 
secondary hypertension.  The majority of all hypertension cases (95%) are said to be 
essential with unknown etiology, while secondary hypertension has a known cause 
(Guyton and Hall, 2000; Staessen et al., 2003).  It is thought that essential hypertension is 
influenced by polygenic and environmental factors or a combination of both (Staessen et 
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al., 2003).  Despite years of research on essential hypertension, specific causes for the 
disease are still not fully understood (Staessen et al., 2003).  Countries in Africa not only 
have significantly higher numbers of people suffering from essential hypertension but 
also show lower levels of awareness and treatment of the disease, which ultimately leads 
to increased risks for morbidity and mortality (Ataklte et al., 2015; Kayima et al., 2013).  
Thus, it is crucial to investigate the possible causes for hypertension in African countries 
in order to lower the escalating disease burden there.   
Hypertension in Kenya 
Kenya, a LMIC located in East Africa, has a population of ~47 million people.   It 
is estimated that 45.2% of Kenyans live below the poverty line of Kenyan shillings (Ksh) 
1,562 ($15.08) and Ksh 2,913 ($28.12) per rural and urban households per month 
respectively (Ngugi, 2013).  Despite rapid urbanization, the majority (74.4%) of Kenyans 
live in rural areas where the availability of health care is scarce (“The World Factbook: 
KENYA”, 2017).  According to the World Bank, Kenya is at the low-end globally for the 
number of physicians, with only 20 per 100,000 people (“The World Bank”, 2014).  By 
comparison, the United States of America has 250 physicians per 100,000 people.  The 
shortage of doctors leads to lack of access to healthcare, especially in rural areas.  
Specifically, elevated BP in rural areas of Kenya was reported to be managed in less than 
3% of all cases (Mwita et al., 2013).  This number might be even lower considering that 
only 18% of Kenyan people are aware of hypertension (Hendriks et al., 2012).  The lack 
of information about hypertension is an additional risk factor, especially for older people, 
since age and elevated BP are positively correlated.  In twenty years, the number of 
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individuals above age 60 is foreseen to be higher than children under 10 with almost 
three quarters of the world’s elderly living in developing countries like Kenya (van de 
Vijver et al., 2013).    
This study takes place in Kasigau, located in the southeast of Kenya, in the Taita-
Taveta District.  As shown in Figure 3, the Kasigau region has five villages surrounding 
Mount Kasigau: Rukanga, Jora, Bungule, Makwasinyi, and Kiteghe.  Ngambenyi and 
Buguta are additional villages included in the study that do not directly associate with the 
mountain but are within 1 and 14 km of it respectively and belong to the Kasigau region.  
Altogether, the seven villages have a population of ~13,000 people (Ngugi, 2013).  
Residents of Kasigau are subsistence farmers, although they are frequently unable to 
grow crops due to scarce rains and wildlife conflicts.  According to Ngugi (2013), only 
~18% of the Kasigau people work for pay which makes them very vulnerable to health 
care problems.  Kenya makes a good research model country for expanding our 




















Since 2008, a team of U.S. physicians led by Dr. Nancy Rice and accompanied by 
Western Kentucky University (WKU) students have traveled to Kasigau and provided 
medical assistance and education for the local people through WKU’s Partners in Caring: 
Medicine in Kenya (PiC:MiK) program.  Clinical work along with self-reported cases 
revealed that essential hypertension is prevalent in the region.  Preliminary 
epidemiological research has shown that 70 % of the local population (age 45 years old 
and above) has elevated BP with no correlation to known risk factors such as high 
cholesterol, lack of physical activity, tobacco use, etc.  (Williams, 2012).   Since no 
A 
B 
Figure 3.  Map of Kenya and Kasigau.  (A) Overview map of Kenya.   
(B) Zoomed-in view of Mt. Kasigau with surrounding villages.  From the very top and 
clockwise: Buguta, Kiteghe, Makwasinyi, Bungule, Jora, Ngambenyi and Rukanga.  
Source: Google Earth. 
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known typical risk factors have been identified, a hypothesis was made that a potential 
cause might be increased sensitivity to sodium (Na+) through dietary salt consumption.    
Physiology and Renal Blood Pressure 
In order to understand hypertension, it is important to know the basic physiology 
of BP.  With each heartbeat, blood is pumped out with a certain force (BP) in the 
circulation.  Maximum arterial BP is referred to as systolic, whereas minimum arterial BP 
is referred to as diastolic.  In order to keep blood flowing in the circulatory system, a 
difference between systolic and diastolic BP is needed.  Hemodynamics, or dynamics of 
blood flow, is controlled by the circulatory system in order to maintain homeostasis. 
Blood is a complex fluid that includes plasma (liquid portion) and formed elements, such 
as red and white blood cells and platelets.  According to the American Red Cross , water 
(~92%) is the main component of plasma while proteins make up 7%, and other solutes 
like mineral salts, fats, and vitamins make up only 1% (”Blood Components”, n.d.).  
Thus, a change in water and salt balance can increase BP in several ways (Johns et al., 
2011) including increased blood vessel resistance, increased blood volume and reduced 
blood flow via renal dysfunction (Drenjancevic-Peric et al., 2011; Osborn & Foss, 2016).  
Renal (ultrafiltration) physiology is an important component in maintaining 
healthy BP via homeostasis of water and salt.  Ultrafiltration occurs in the Bowman’s 
(glomerular) capsule in kidneys when blood flows into a dense network of capillaries.  
Due to BP force and a differential concentration gradient, small molecules like water, 
urea, glucose, amino acids and salts are filtered through arterioles into renal tubules 
(Koushanpour, 1986).  The filtered fluid is then modified by reabsorption of useful 
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solutes back into the circulation of blood and secretion processes, which produces urine.  
If there is a decrease in BP, a reduction of blood flow results, which then decreases the 
glomerular filtration rate via decreased levels of Na+ in macula densa.  Ultimately, this is 
fixed by increasing reabsorption of Na+ which also leads to osmosis and increased 
volume of plasma.  Ultrafiltration in the kidney is a main control mechanism for blood 
volume (Ehlenz, 1995).  Since blood volume can directly affect cardiac output, it also is 
able to manipulate blood pressure.  
Salt-sensitive Hypertension and the Renin-Angiotensin System 
Salt-sensitivity is when an individual’s BP fluctuates depending on their Na+ 
intake (Richardson et al., 2013).  It is recommended that Na+ intake per day ranges from 
1.5 – 2.4 g which equals 3-5 grams of table salt per day (O’Donnell et al., 2014; WHO, 
2012b) which is more than sufficient for bodily needs (Adrogue & Madias, 2007).  
Despite the recommended levels, the average global Na+ consumption has been 
increasing over time from 3.95 g/day in 2010 to 4.93 g/day in 2014 (Mozaffarian et al., 
2014; O’Donnell et al., 2014).  Elevated levels of consumption are a big concern because 
they can lead to essential hypertension and CVD (Mozaffarian et al., 2014; O’Donnell et 
al., 2014).   
Multiple genetic factors impact BP and an individual’s sensitivity to dietary salt.  
The renin-angiotensin system (RAS) is the most studied and physiologically significant 
complex hormonal system that controls salt balance and BP homeostasis (Drenjancevic-
Peric et al., 2011; Giner et al., 2000; Mendoza & Lazartigues, 2015).  When there is a 
drop in BP, it is detected in the kidney in specialized arteriole (juxtaglomerular) cells and 
renin is generated. 
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At the same time, the liver excretes inactive angiotensinogen (AGT) protein 
which is then converted to active angiotensin I (Ang-I) by renin.  Upon activation, Ang-I 
is transported via the blood stream to the lungs where it is further converted to 
angiotensin II (Ang-II) by angiotensin converting enzyme (ACE).  Ang-II is a potent 
vasoconstrictor meaning it can regulate the narrowing of blood vessels via regulation of 
smooth muscle contraction, increasing blood flow and cardiac output.  Ang-II can 
influence various other pathways as well such as the secretion of aldosterone in adrenal 
glands which increases reabsorption of Na+ and water in the nephron leading to 
hypertension (Figure 4).  Each of the polypeptides involved in the RAS system are 
encoded by a separate gene.  One of the ways to target hypertension is to prevent Ang-II 
formation by inhibiting enzymes (renin or ACE) that facilitate the pathway (Mendoza & 
Lazartigues, 2015).  A number of people have impairments in the RAS system and are 
not able to excrete Na+ and water appropriately. 
Figure 4.  Renin-Angiotensin System (RAS). Arrows refer to the Angiotensin-II 





Salt-sensitivity in a Hypertensive Cohort in Kenya 
Kenyan people from the Kasigau region could possibly be genetically predisposed 
for salt-sensitive essential hypertension.  According to Richardson et al. (2013), 75 % of 
hypertensive salt-sensitive individuals are non-Hispanic blacks, with other studies 
showing a positive correlation between Na+ intake and hypertension in African 
populations (Tayo et al., 2012).  Epidemiological studies suggest that it takes 
significantly less dietary salt to develop hypertension for Africans than Caucasians due to 
an evolutionary maladaptation in RAS (Drenjacevic-Peric et al., 2011).  In addition, some 
studies argue that the main cause of elevated BP in aging populations is due to rising salt 
consumption.  A study on Yanomamo Indians revealed that incredibly low salt intake 
does not lead to increasing BP with age, with prevalence of hypertension at only ~5%, as 
would be expected in African population before westernization (Drenjacevic-Peric et al., 
2011).  As more African societies become westernized, their consumption of processed 
food, which is high in salt, increases which can lead to elevated BP.   
Likewise, there has been some evidence positively correlating chloride (Cl-) to 
high BP, and it is important to acknowledge it because Na+ and Cl- can come from 
different sources (McCallum & Lip, 2015).  Conversely, studies done by Hajjar et al. 
(2006) have shown a negative correlation in high potassium (K+) intake and 
hypertension.  Thus, a Na+/K+ ratio can also be used as an indicator for hypertension 
since several studies have shown that a positive correlation exists between an increase in 
BP and a corresponding increase in Na+/K+ (Hedayati et al., 2012).  Hence, salt sensitive 
hypertension does not only refer to dietary Na+ intake, it can also be influenced by other 
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diet components: K+, Cl-, fat, etc.  (McCallum & Lip, 2015).  This study will evaluate 
Na+, K+ and Cl- excretions in urine in order to extrapolate salt consumption in a Kenyan 
cohort living in the Kasigau area.  This work will provide important information 
regarding whether the observed hypertension in this population may be a result of salt-
sensitivity. 
While 24-hour urine (24HU) collection has traditionally been the standard 
protocol for determining salt consumption, this technique is limited by difficulty on the 
part of the patient and lack of compliance.  Recently, multiple studies have shown that 
Na+ excretion can be effectively estimated from spot urine (SU) samples and SU samples 
correlate well with 24HU samples.  Therefore, SU can be used as an estimate of Na+/K+ 
ratios in urine samples (Brown et al., 2013; Kawasaki et al., 1993; Mill et al., 2015; 
Tanaka et al., 2002; Wang et al., 2013).    
Moreover, Mill et al. (2012) showed that nocturnal 12-h urine collection 
correlates to 24HU collection, making 12-h urine collection useful in epidemiological 
studies.  In the study, two collection periods were established: nocturnal (overnight: 
between 1900 and 0700 h) and diurnal (over day: between 0700 and 1900 h).  It was 
found that nocturnal urine collection represents 47% (Na+) and 39% (K+) of 24HU 
collection.  Averaged and divided by 0.47 or 0.39 for Na+ and K+, these values are a good 
representation of 24HU electrolyte excretion.  Hence, evening and morning SU values 
represent nocturnal urine electrolyte values.   
Thus, I will test the hypothesis that the high rate of hypertension in Kenyan 
individuals is due to a high dietary Na+ intake.  To test this hypothesis, I will use a two 
14 
 
SU analysis (evening and overnight) based upon the method of Mill et al. (2012), since 
these SU samples are a good representation of 12-h (overnight) urine collection and can 






MATERIALS AND METHODS  
 
Ethics Review and Compliance  
This study was approved by Western Kentucky University’s Human Subject 
Review Board (IRB 14-387, Appendix A) and the Taita District Health Officer in Kenya, 
the University of Nairobi Ethics Review Board (Appendix B) as well as the village 
chiefs/elders.  Participants were provided an informed document that they either read or 
was read to them.  This document explained the study purpose and goals to identify salt 
excretion in the samples and individuals voluntarily consented to participate. 
Study Participants 
Study participants were recruited from the seven Kasigau villages: Buguta, 
Makwasinyi, Rukanga, Bungule, Ngambenyi, Kiteghe, and Jora.  Participants in this 
study were a subset of a longitudinal study in our lab (Williams, 2012).  Initially, 
participants were selected as a random sample of the normal population and included 
males and non-pregnant females, ages 45 and above.   
Urine Stability Tests 
Because field sampling in Kenya lacks many common sample storage abilities, 
prior to data collection in Kenya, urine stability tests were performed.  Urine samples 
were tested for Na+, K+ and Cl- electrolyte stability in a sample over time; 0h, 24h, 48h 
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and 72h.  Urine samples were also tested for Na+, K+ and Cl- electrolyte stability after 
24h at room temperature (~23 ̊C), 4̊ C and –20 ̊C. 
Urine Sampling Protocols 
To increase compliance in this study, the SU sampling approach was chosen over 
24HU sampling.  Spot urine samples have been proven to be a good indicator of 24HU 
collection, therefore it is a good indicator of dietary salt intake (Kawasaki et al., 1993; 
Mill et al., 2015; Wang et al., 2013).  Over the course of two months, seven community 
meetings, barazza, were held for study participants in each of the Kasigau sub-locations: 
Buguta, Makwasinyi, Rukanga, Bungule, Ngambenyi, Kiteghe, and Jora.  Participants as 
a group were given a verbal explanation of the study aims along with instructions for 
urine sample collection.  A translator assisted in this phase of the project.  Each 
participant was instructed to collect an evening (between 1800 and 2359 h) and overnight 
(between 0400 and 0900 h) urine sample.   Each participant was given two of each of the 
following items for sample collection: Dixie cup, previously labeled 15 mL falcon tube,   
3 mL disposable plastic transfer pipet, and a towelette.  Instructions on collection process 
were provided in English (Appendix C) and Swahili (Appendix D).  Individuals either 
read these instructions or the instructions were read to them.  Study participants were to 
transfer the void from the Dixie cups to corresponding falcon tubes for morning and 





Anthropometric Data Collection 
BP measurements were taken after each participant received instructions on how 
to collect the samples.  In order to obtain the most accurate BP results, all individuals 
were asked to be seated and remain seated for at least five minutes without talking and 
with both flat feet touching the floor prior to BP measurement (Frese et al., 2011).  BP 
was measured using an automatic BP monitor by Omron (model: BP742N, Omron 
Healthcare, Inc.).  Participants were classified as either: normotensive (below 120 mmHg 
systolic BP /80 mmHg diastolic BP), pre-hypertensive (120-140 / 80-90 mmHg), Stage I 
(140-160 / 90-100 mmHg) or Stage II (above 160/100 mmHg) categories (WHO, 2014a; 
Richardson et al., 2013).  Systolic BP is a more accurate predictor for cardiovascular 
problems than diastolic BP especially among older populations, so systolic value is the 
primary comparison tool that is used in this study (Hajjar et al., 2006).  Two blood 
pressure measurements were taken from each individual and the average of both systolic 
BP measurements was used for statistical correlations.  Study participants also were 
asked if they were currently using any antihypertensive medicine.   
Other anthropometric data, such as, age, body weight (kg), height (cm), waist to 
hip ratio was obtained from the preliminary work done in the same community by 
Lindsay Williams (2012).  Body mass index (BMI) was calculated as kg/m2.  Based on 
BMI, participants were divided into the following categories: underweight (< 18.5 
kg/m2), normal (18.5 – 25 kg/m2), overweight (25 – 30 kg/m2), and obese (> 30 kg/m2) 




Urine Sample Collection and Analysis 
Urine samples were collected and analyzed within 6 - 48 hours.  A Diamond 
Diagnostics Smartlyte Electrolyte Analyzer was used to perform the electrolyte analysis.  
Each sample was diluted to a ratio of 1 part urine sample (1 ml urine) to 2 parts urine 
diluent (2mL urine diluent) (AV-BP0344D, Diamond Diagnostics).   Samples were then 
analyzed for Na+ and Cl- concentrations.  Before measuring K+, the diluted urine samples 
were diluted one more time with distilled water in a 1:2 ratio respectively.  Potassium 
values were subsequently multiplied by 3 to control for the dilution factor.  Samples that 
were below 15 mmol/L for K+ prior to the dilution were not diluted further.  Subjects 
who failed to collect at least 3mL of void for each of the morning and evening samples 
were excluded from the study.   
The Smartlyte Electrolyte Analyzer uses a calibration curve based on measured 
points of standard solutions with known ion concentrations.  The calibration procedure, 
either 2-point or 3-point, was performed automatically every 4 hours or after 100 
analytical runs, whichever came first.  A 1-point calibration was automatically performed 
with each sample measurement.  Quality control and standard cleaning and conditioning 
procedures were executed every time after powering on the Smartlyte Electrolyte 
Analyzer.  These included using commercially prepared reagents from Diamond 
Diagnostics: Mission Control 1-2-3 standards (DD-92123) for quality control tests; ISE 
Cleaning Solution (AV-BP1025D) and Electrode Conditioning Solution (AV-BP0380D) 
for cleaning and conditioning, respectively.  Each urine sample was measured as a 
duplicate and the average of both trials were used for statistical analysis.  Prior to data 
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analysis, averaged crude SU sample values were divided by 0.47 and 0.39 for Na+ and K+ 
respectively in order to represent 24HU collection (Mill et al., 2012).  These values were 
used in further data analysis.   
Statistical Analysis 
Statistical analysis was performed using the SigmaPlot 11.0 package (Systat 
Software, Inc, USA).  Statistical relationships between electrolyte excretion and 
anthropometric data were analyzed via linear regression and overall anthropometric 
population data were analyzed statistically by t-test.  If a data set failed the normality test, 
Mann-Whitney Rank Sum test was applied.  P values of < 0.05 were used to infer 






Urine Stability Tests 
Since the Kasigau area does not have reliable electricity, samples collected in the 
field would not be able to be refrigerated, frozen or transported to the USA for analysis.  
Thus, prior to our sample collection in Kenya, random urine samples were tested for 
stability of electrolyte quantification at room temperature (~23 ̊C) at 0h, 24h, 48h and 
72h.  Urine samples were also tested after 24 h at 4 ̊C, and after one round of freezing at -
20oC and thawing at room temperature.  The average temperature during the data 
collection period in Kenya ranged from 20 ̊C to 28 ̊C, which is within the range of room 
temperature (~23 ̊C) during stability testing.  
Regardless of storage temperature, after 24h, no significant differences in Na+ and 
Cl- were observed in comparison with 0h; the highest differences were 6.7 mmol/L for 
Na+ and 10.3 mmol/L for Cl- (Table 1).  After 48h and 72h, Sample 1 indicated slightly 
higher values when compared to 0 h for Na+ and Sample 2 had slightly higher values for 
Cl-, which were likely a result of improper mixing of the stationary samples prior to 
analysis.  K+ levels varied the most when compared to 0 h (Table 1). Such variation could 
not be explained by error coming from serial dilutions and mixing efficiency.  Therefore, 
since K+ values did not appear to be stable over time, commercially prepared quality 
control tests were executed (Mission Control 1-2-3, Diamond Diagnostics) which led to 
the replacement of the K+ electrode.  After the K+ electrode was replaced, another 
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stability test was performed and this time K+ values did not fluctuate (Table 2).  Thus, it 
was concluded that SU samples are stable at room temperature for up to 48 h.  
 
Table 1. SU stability tests in different temperatures (~23 ̊C, 4 ̊C and – 20 ̊C) and different 
time (0h, 24h, 48h, 72h); values represent the average of three measurements, ± S.D. 


















Na+ 198.8 ± 3.2 201.0 ± 0.9 202.7 ± 3.5 200.7 ± 2.5 207.0 ± 0.0 211.5 ± 4.4 
K+ 41.8 ± 1.8 40.2 ± 1.0 75.3 ± 48.3 98.0 ± 69.1 80.3 ± 15.8 55.4 ± 11.1 







Na+ 156.0 ± 1.5 153.0 ± 1.6 156.0 ± 1.0 157.0 ± 1.0 157.5 ± 1.3 162.3 ± 0.5 
K+ 42.3 ± 0.8 39.4 ± 5.6 77.3 ± 38.0 94.8 ± 54.1 65.9 ± 7.7 53.0 ± 13.2 
Cl- 159.3 ±  3.8 162.3 ± 1.6 164.3 ± 2.1 166.3 ± 2.5 167.0 ±  1.2 173.3 ± 2.5 
 
Table 2. Multiple analyzes of one SU sample at ~23 ̊C and 0h after changing K+ 
electrode.  







Na+ 197 197 198 197 197 
K+ 28.4 28.2 28.3 28.0 30.2 
K+ 
diluted 
8.3 8.3 8.4 8.4 8.3 









The characteristics of the study population are shown in Table 3.  Out of 142 
participants, 99 were female (69.7%) and 43 were male (30.3%).   The mean age of the 
population was 61.1 ± 11.5 years old, with females (?̅? = 59.3) on average being 
significantly younger than males (?̅? = 64.5), t-test value p = 0.021.  Systolic BP, body 
weight and height were similar between sexes, whereas, BMI was significantly higher    
(p = 0.002) and waist-to-hip ratio was significantly lower (p < 0.001) in females 
compared to males, although an average values were within the normal ranges.  Complete 
urine samples and BP measurements were collected from a total of 135 participants.  
Average urine electrolyte excretion values for Na+ and K+ are expressed as estimated 
24HU electrolyte values with standard deviations: 170.6 ± 89.3 mmol/L, 82.0 ± 54.0 
mmol/L, respectively.  Chloride values are expressed as mean SU values since there is no 
literature which calculates an estimated 24HU Cl- from overnight urine collection.  Study 
population mean for Cl- was calculated to be 87.7 ± 42.1 mmol/L.  The normal ranges for 
adults for the three electrolytes should fall into the following ranges: Na+ 40 – 220 
mmol/L; K+ 25 – 125 mmol/L; Cl- 110 – 250 mmol/L (University of Rochester Medical 
Center, n.d.).  Females had higher mean values for each of the urine electrolytes than 
males, but only K+ excretion was statistically significant (Figure 5) (Mann-Whitney Rank 
Sum Test, p = 0.016).  The Na+/K+ ratio in females was lower than males, but not 




Table 3.  Characteristics of study population.  Values are expressed as means ± standard 
deviation or percentage as appropriate.  An * indicates a significant difference between 
females and males (p < 0.05) 
 Total 
𝑥 ̅ ± 𝑆. 𝐷. 
Men 
𝑥 ̅ ± 𝑆. 𝐷. 
Women 
𝑥 ̅ ± 𝑆. 𝐷. 
Sample size, n 142 43 (30.3) 99 (69.7) 
Age (years) 61.1 ± 11.5 64.5 ± 12.0 59.3 ± 10.8* 
Systolic BP (mmHg) 151.1 ± 28.9 152.0 ± 24.8 150.7 ± 30.7 
Body weight (kg) 58.6 ± 14.2 58.4 ± 12.5 58.9 ± 15.0 
Height (cm) 155.2 ± 9.0 162.3 ± 8.1 151.8 ± 7.2 
Body Mass Index (kg/m2) 24.8 ± 6.0 22.6 ± 5.0 25.9 ± 6.2* 
Waist-to-hip ratio 0.92 ± 0.35 0.97 ± 0.41 0.89 ± 0.32* 
Estimated 24HU Na+ (mmol/L) 170.6 ± 89.3 168.4 ± 69.4 173.3 ± 97.0 
Estimated 24HU K+ (mmol/L) 82.0 ± 54.0 68.7 ± 53.8 87.2 ± 52.8* 
SU Cl- (mmol/L) 87.7 ± 42.1 83.3 ± 29.3 90.0 ± 46.5 
Estimated daily Na+ (g/day) 3.93 ± 2.0 3.86 ± 1.6 4.03 ± 2.2 
Estimated daily K+ (g/day) 3.21 ± 2.1 2.85 ± 2.2 3.39 ± 2.1 




Figure 5.  Electrolyte excretion for females and males in the study population.         




Electrolyte Excretion Comparison by Hypertensive Category 
Electrolyte excretion values were categorized based upon the BP of each 
participant and sex as follows: normotensive (n = 17), pre-hypertensive (n = 43), 
hypertensive stage I (n = 33) and hypertensive stage II (n = 49).  Hypertensive 
individuals, on average, showed the highest amount of Na+, K+ and Cl- excretion when 
compared to normotensive and pre-hypertensive participants (Table 4).  However, when 
hypertensive stage I vs. stage II are subdivided, there is no trend.  Only Na+ excretion 
showed a significant difference between hypertensive and normotensive p < 0.05 (t-test    

















Table 4.  Mean systolic BP and urine electrolyte excretion means for normotensive, pre-
hypertensive and combined hypertensive stage I & II categories.  Hypertensive I & II is 
also subdivided into Stage I and Stage II below.  Values are expressed as means ± 
standard deviation or percentage as appropriate.  A * indicates significantly different 
values when compared to normotensive values. 
 Total 
𝑥 ̅ ± 𝑆. 𝐷. 
Men 
𝑥 ̅ ± 𝑆. 𝐷. 
Women 
𝑥 ̅ ± 𝑆. 𝐷. 
Normotensive (%) 17 (12.0) 5 (11.0) 12 (12.5) 
   Systolic BP (mmHg) 109.1 ± 8.2 108 ± 7.7 109.3 ± 8.6 
   Estimated 24HU Na+ (mmol/L) 123.2 ± 85.0 163.8 ± 83.8 125.8 ± 91.7 
   Estimated 24HU K+ (mmol/L) 61.0 ± 44.6 40.0 ± 15.7 66.4 ± 47.9 
   SU Cl- (mmol/L) 65.5 ± 30.6 74.7 ± 32.0 66.3 ± 31.8 
Pre-hypertensive (%)  43 (30.3) 10 (21.7) 33 (34.4) 
   Systolic BP (mmHg) 129.7 ± 5.8 128.0 ± 5.6 130.2 ± 5.8 
   Estimated 24HU Na+ (mmol/L) 172.9 ± 95.0 178.7 ± 84.1 171.1 ± 99.2 
   Estimated 24HU K+ (mmol/L) 94.6 ± 67.0 86.9 ± 94.9 96.9 ± 57.7 
   SU Cl- (mmol/L) 86.2 ± 42.3 85.5 ± 33.7 86.5  ± 45.1 
Hypertensive Stage I & II 82 (57.7) 31 (67.4) 51 (53.1) 
   Systolic BP (mmHg) 170.3 ± 21.4 164.0 ± 18.3 174.2 ± 22.4 
   Estimated 24HU Na+ (mmol/L) 178.2 ± 85.3* 165.8 ± 64.1 185.9  ± 94.9 
   Estimated 24HU K+ (mmol/L) 79.1 ± 46.4 67.4 ± 36.9 87.2 ± 50.0  
   SU Cl- (mmol/L) 92.6 ± 42.8 84.0 ± 28.2 97.9 ± 48.8 
 Hypertensive Stage I  33 (23.2) 15 (34.9) 18 (18.2) 
    Systolic BP (mmHg) 150.8 ± 7.3 148.2 ± 7.0 152.9 ± 6.9 
    Estimated 24HU Na+ (mmol/L) 189.1 ± 83.8 176.7 ± 60.3 199.5 ± 99.8 
    Estimated 24HU K+ (mmol/L) 89.2 ± 56.4 77.2 ± 44.2 99.3 ± 64.3 
    SU Cl- (mmol/L) 96.7 ± 41.3 92.0 ± 28.8 100.7 ± 49.9 
 Hypertensive Stage II 49 (34.5) 16 (37.2) 33 (33.3) 
    Systolic BP (mmHg) 183.7 ± 17.0 178.8 ± 11.8 186.1 ± 18.9 
    Estimated 24HU Na+ (mmol/L) 170.7 ± 86.4 155.7 ± 67.9 178.5 ± 92.9 
    Estimated 24HU K+ (mmol/L) 72.2 ± 37.2 58.3 ± 26.8 80.8 ± 39.7 





When the estimated 24HU Na+, K+, and SU Cl- electrolyte excretion were 
compared, all individuals, regardless of BP, have normal excretion levels for Na+ (40 – 
220 mmol/L) and K+ (25 – 125 mmol/L), but are under the normal excretion levels for Cl- 
(110 – 250 mmol/L) (Figure 6, Table 4).  Analysis of each electrolyte excretion value 
showed that there is a significant difference between normotensive and hypertensive 
stage I individuals for estimated 24HU Na+ (p= 0.015) and SU Cl- excretion (p = 0.037).  
While not significant (p = 0.053), these same individuals also showed a difference in 
estimated 24HU K+ excretion values.   
 
Figure 6.  Electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 








When data were separated by sex there were no statistically significant 
differences between hypertensive categories for any electrolyte within the same sex or 
between males and females of the study cohort (Figure 7).  Generally, there is an increase 
in electrolyte excretion as BP increases, with the exception of hypertensive stage II 
individuals.  This may be due to the small sample size of the overall study.  The 
estimated 24HU K+ excretion for males does not follow this trend. 
Normotensive females and those with stage I hypertension did show differences 
between 24HU Na+ and SU Cl- values (p = 0.050) and between normotensive and stage II 
(p = 0.059), although these were not statistically significant.  The biggest difference 
between males and females was observed in hypertensive stage II individuals for K+    









Figure 7.  Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 








Electrolyte Excretion Comparison by Age  
Individuals in each of the hypertensive categories varied in age from 40 to >70 
years (Table 5).  The most hypertensive stage I & II individuals (n = 28; female 16, male 
12) are ≥ 70 years old, followed by individuals 50 – 59 (n = 24; female 17, male 7),       
60 – 69 (n = 17; female 12, male 5), and 40 – 49 (n = 11; female 7, male 4).  On average, 
there were 12 pre-hypertensive individuals (dominated by women due to larger female 
sample size overall, n = 7) in all age categories except 70 and above.  There were equal 
number (n = 5) of normotensive individuals in age groups 40 – 49 and 50 – 59 (females 
only), which decreased to 3 individuals in age 60 – 69 and 2 individuals (only males) in 
the group above 70. 
When mean systolic BP values and age were compared, in general a positive 
linear correlation exists for both males and females, as expected, with the exception of 
females aged 60 – 69 (Figure 8).  Lower mean systolic BP value for females of ages 60 – 
69 might be related to a smaller overall sample size when compared to women ages 50 – 
59.  Differences of systolic BP between male and female matched age categories were 
not significant (p > 0.05).  Differences of systolic BP within the same sex, indicated that 
40 – 49 year old females have significantly lower BP than females of ages 50 – 59 (p = 
0.048), 60 – 69 (p = 0.047) and ≥ 70 (p = 0.002), whereas males ages 50 – 59 have 
significantly lower systolic BP than males ≥ 70 years old (p = 0.045). There was a large 
difference in systolic BP between males age 40 – 49 and males ≥ 70 years old, however it 




Table 5.  Mean systolic BP and urine electrolyte excretions for overall study population, 
males and females, divided by age.  Values are expressed as means of urinary electrolytes 
(mmol/L) ± standard deviation.  A* indicates significant differences between male and 
same age female. 
 Total Men Women 
 142 43 99 
Age 40-49 30 (21.1) 6 (14.0) 24 (24.2) 
      Systolic BP (mmHg) 137.3 ± 23.4 116.7 ± 6.0 136.8 ± 25.6 
      Estimated 24HU Na+ (mmol/L) 164.0 ± 83.0 175.7 ± 56.1 164.9 ± 89.5 
      Estimated 24HU Na+ (mmol/L) 85.1 ± 52.2 85.5 ± 54.2 83.4 ± 52.3 
      SU Cl- (mmol/L) 82.5 ± 36.6 89.7 ± 32.0 82.0 ± 38.0 
Age 50-59 41 (28.9) 11 (25.6) 30 (30.3) 
      Systolic BP (mmHg) 151.4 ± 32.4 129.4 ± 18.1 154.5 ± 35.8 
      Estimated 24HU Na+ (mmol/L) 186.2 ± 96.6 203.1 ± 78.3 181.2 ±101.7 
      Estimated 24HU Na+ (mmol/L) 97.5 ± 70.4 93.8 ± 88.6 96.8 ± 64.0 
      SU Cl- (mmol/L) 96.7 ± 48.4 96.3 ± 29.2 96.1 ± 53.6 
Age 60-69 33 (23.2) 9 (20.9) 24 (24.2) 
      Systolic BP (mmHg) 149.0 ± 27.0 145.1 ± 26.8 150.4 ± 27.5 
      Estimated 24HU Na+ (mmol/L) 159.3 ± 88.0 121.2 ± 52.3 173.6 ± 95.1 
      Estimated 24HU Na+ (mmol/L) 72.7 ± 48.8 40.1 ± 27.2* 84.9 ± 49.8 
      SU Cl- (mmol/L) 83.8 ± 41.2 65.2 ± 22.8 90.8 ± 44.7 
Age 70 and above 37 (26.1) 17 (39.5) 20 (20.2) 
      Systolic BP (mmHg) 162.5 ± 25.9 168.7 ± 24.9 162.5 ± 26.0 
      Estimated 24HU Na+ (mmol/L) 173.3 ± 85.9 167.8 ± 72.1 178.0 ± 97.8 
      Estimated 24HU Na+ (mmol/L) 71.4 ± 33.7 65.3 ± 28.8 76.5 ± 37.3 





      
Figure 8.  Mean systolic BP values of males and females divided by age.  Values 
represent mean systolic BP (mmHg) ± standard error.  Color coded asterisks mark 
significant differences between age groups for females (red) and males (black). 
 
Analysis of mean electrolyte excretion indicates both males and females of all 
ages excrete normal levels of estimated 24HU Na+ and K+, but below normal urinary 
electrolyte levels of SU Cl- (Figure 9, Table 5).  Men between 60 – 69 years of age 
excrete the lowest levels of Na+ (121.2 ± 52.3 mmol/L) and SU Cl- (65.2 ± 22.8 mmol/L) 
when compared to females (173.6 ± 95.1 mmol/L and 90.8 ± 44.7 mmol/L, respectively) 
and males of all ages (168.4 ± 69.4 mmol/L and 83.3 ± 28.3 mmol/L), however these 
differences are not statistically significant.  Also, males 60 – 69 years old excrete the 
lowest levels of estimated 24HU K+ (40.1 ± 27.2 mmol/L) although still within normal 
ranges.  There is a significant difference in estimated 24HU K+ excretion between         
60 – 69 years old males when compared to matched females (p = 0.007) (Table 5).  This 














































60-69  male group to all age female (p = 0.004) and all age male (p = 0.025) individuals 
(Table 5). 
Individuals who are 50 – 59 have the highest recorded electrolyte excretion values 
for all three ions, Na+, K+ and Cl- (Figure 9, Table 5).  Males in this age group also have 
the highest estimated 24HU Na+ (203.1 ± 78.3 mmol/L) overall.  Although excreted 
electrolytes are higher in the 50 – 59 age group for both males and females, the systolic 
BP readings are not (Figure 8).  These results may imply that age is a larger contributing 
factor to high systolic BP than Na+, K+ and Cl- levels.   
 
Figure 9.  Mean electrolyte values of estimated 24HU Na+, K+ and SU Cl- for study 





Linear Regression Analysis – Sodium  
When the relationship between individual Na+ excretion and individual systolic 
BP was statistically assessed by linear regression, there was no strong correlation             
(r = 0.0935) between estimated 24HU Na+ excretion and systolic BP (Figure 10a).  
Interestingly with increasing age the correlation between systolic BP and Na+ excretion 
decreases when stratified by both sex and age. When categorized by each age 
demographic, again there is no strong correlation between observed Na+ excretion and 
systolic BP (Figures 11 and 12).  Females do exhibit a slight positive correlation between 
estimated 24HU Na+ excretion and systolic BP that is not observed in males, r = 0.0983 






















Figure 10.  Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic 
BP (mmHg).  (a) overall study population; (b) individuals ages 40-49; (c) individuals 
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Figure 11.  Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic 
BP (mmHg) for females.  (a) overall female population; (b) individuals ages 40-49; (c) 





r = 0.0983 
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Figure 12.  Relationship between estimated 24HU Na+ excretion (mmol/L) and systolic 
BP (mmHg) for males.  (a) overall male population; (b) individuals ages 40-49; (c) 





r = 0.0172 
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Linear Regression Analysis – Potassium and Chloride 
When individual estimated 24HU K+ and SU Cl- excretion values were analyzed, 
there was no statistically significant correlation between excreted ions and systolic BP    
(r = – 0.0678 and r = 0.0126 respectively) (Figure 13a).  Interestingly the relationship 
between systolic BP and estimated 24HU K+ levels, is consistent with other work in that 
K+ has a negative correlation with systolic BP, even though the correlation is very small.  
Spot Cl- excretion values demonstrate a similar trend to Na+ excretions.  This was not 
unusual in that for most individuals Cl- intake comes from table salt (NaCl).  After 
analyzing estimated 24HU K+ and SU Cl- excretion values for each sex separately 
(Figures 13b, 13c), it seems that males contribute negatively to the overall K+ and 
systolic BP correlation (males r = – 0.194, females r = – 0.0417) while females contribute 


















     
 
 
Figure 13.  Relationship between electrolytes excretion (mmol/L) for estimated 24HU K+ 
and SU Cl- vs. systolic BP (mmHg).  (a) overall population; (b) female population; (c) 
male population.    
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Electrolyte Excretion Comparison by BMI  
When the ion excretion data was stratified based upon four BMI (underweight    
(n = 11), normal weight (n = 63), overweight (n = 29) and obese (n = 24)), overweight 
individuals of both sexes have the highest average systolic BP values: males 166.3 
mmHg, females 160.6 mmHg, followed by obese individuals with systolic BP of 150.0 
mmHg and 154.2 mmHg for males and females, respectively (Figure 14).  The lowest 
average systolic BP values are seen in normal weight and underweight individuals of 
both sexes.  There is a statistically significant difference between normal weight and 
overweight individuals (p = 0.013) (Figure 14), although no significant differences 
between systolic BP between males and females in matched BMI category or between 
different BMI categories within the same sex, with the exception of normal weight and 
overweight females (p = 0.038).  While the systolic BP difference between normal weight 
and overweight male individuals was also high, it was not significant (p = 0.1). All four 
BMI groups of males and females, based on the systolic BP, fall within hypertensive I & 





Figure 14.  Mean systolic BP values of males and females divided by BMI.  Values 
represent mean systolic BP (mmHg) ± standard error.  Asterisk mark significant 
differences between BMI groups for females (red). 
 
Individuals were evaluated divided based upon their BMI, analyzed for electrolyte 
excretion and compared to one another for each of the excreted ions (Figure 15, Table 6).  
On average, underweight and overweight individuals excreted similar levels of Na+ and 
Cl-, but less than obese individuals.  Individuals with higher BMI, on average were 
excreting higher levels of estimated 24HU Na+ and SU Cl- with the exception of 
underweight individuals.  Significant differences were observed between normal weight 
and obese individuals for estimated 24HU Na+ (149.5 ± 78.7 vs. 219.2 ± 86.4) and SU Cl- 
excretions (76.4 ± 36.8 vs. 96.2 ± 44.2), p < 0.001 for both.  Although not statistically 
significant (p = 0.058), the difference of K+ level between normal weight and obese 








































underweight and normal weight vs. overweight individuals did not show statistically 
significant differences for SU Cl-, p = 0.051 and p = 0.090 respectively.   
 
   
Figure 15.  Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 
different BMI categories. Values represent means ± standard error. 
 
 
Stratification of the study cohort by sex and comparison of mean excreted ions 
between males and females of matched BMI, indicated that the only significant 
difference was between normal weight individuals for estimated 24HU K+ excretion (p = 
0.025, Table 6).  While, underweight individuals excreted very different Na+ values 
(males 205.9 ± 77.7 vs. females 110.4 ± 84.2, p = 0.109), the difference was not 
statistically significant (Table 6).  This difference might be influenced by a very small 





Table 6.  Mean systolic BP and urine electrolyte excretion means for underweight, 
normal weight, overweight and obese individuals.  Values are expressed as number of 
individuals (n) or as means ± standard deviation.    
 Total 
𝑥 ̅ ± 𝑆. 𝐷. 
Men 
𝑥 ̅ ± 𝑆. 𝐷. 
Women 
𝑥 ̅ ± 𝑆. 𝐷. 
Underweight  11 8 3 
   Systolic BP (mmHg) 148.0 ± 30.8 147.1 ± 27.3 150.1 ± 46.1 
   Estimated 24HU Na+ (mmol/L) 179.8 ± 87.4 205.9 ± 77.7 110.4 ± 84.2 
   Estimated 24HU K+ (mmol/L) 80.5 ± 48.2 84.2 ± 55.2 70.5 ± 27.4 
   SU Cl- (mmol/L) 100.0 ± 32.5 98.5 ± 29.4  104.0 ± 47.1 
Normal weight  63 23 40 
   Systolic BP (mmHg) 148.5 ± 27.4 147.8 ± 25.4 148.9 ± 28.9 
   Estimated 24HU Na+ (mmol/L) 149.5 ± 78.7 145.8 ± 63.2 151.7 ± 87.1 
   Estimated 24HU K+ (mmol/L) 76.6 ± 57.3 62.9 ± 63.9 84.5 ± 52.4 
   SU Cl- (mmol/L) 76.4 ± 36.8 74.0 ± 28.4 77.8 ± 41.2 
Overweight  29 6 23 
   Systolic BP (mmHg) 161.8 ± 22.8 166.3 ± 14.4 160.6 ± 24.7 
   Estimated 24HU Na+ (mmol/L) 189.9 ± 104.1 164.5 ± 80.3 196.5 ± 110.0 
   Estimated 24HU K+ (mmol/L) 96.8 ± 60.9 75.2 ± 34.9 102.4 ± 65.4 
   SU Cl- (mmol/L) 96.6 ± 48.9 29.3 ± 13.6 100.2 ± 52.3 
Obese  24 5 20 
   Systolic BP (mmHg) 148.1 ± 33.8 158.0 ± 24.0 154.2 ± 38.9 
   Estimated 24HU Na+ (mmol/L) 219.2 ± 86.4 191.6 ± 66.0 224.8 ± 89.0 
   Estimated 24HU K+ (mmol/L) 84.2 ± 37.7 85.8 ± 36.8 82.9 ± 38.1 
   SU Cl- (mmol/L) 96.2 ± 44.2 96.8 ± 27.7 111.4 ± 46.3 
 
 
Analysis of electrolyte excretion between the same sex individuals with different 
BMI determined a couple significant differences for males but not for females (Figure 
16b).  Underweight and normal weight males excreted significantly different levels of 
estimated 24HU Na+ and SU Cl- (p = 0.037, p = 0.046, respectively), while overweight 
and obese males had significantly different estimated 24HU K+ excretion levels (p = 
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0.048).  Underweight males excreted the highest electrolyte values when compared to 
normal weight, overweight and obese males. 
Analysis of female 24HU Na+ excretion indicated a positive correlation between 
Na+ and increasing BMI (Figure 16a, Table 6).  Underweight females excreted the lowest 
Na+ values (110.4 ± 84.2) when compared to normal weight (151.7 ± 87.1), overweight 
(196.5 ± 110.0) and obese (224.8 ± 89.0). However comparison between two BMI groups 
(underweight vs. overweight and underweight vs. obese) indicated no significance, p = 
0.168, p = 0140 respectively. Analysis of normal weight and obese female excretion of 
Na+ was not significant, p = 0.086, likely due to small sample size of underweight 
females.  A similar trend between mean excretion levels and BMI was also seen in 
estimated 24HU K+ with the exception of obese females that did not excrete the highest 
values.  Normal weight and obese females had the highest difference between 24HU K+ 
excretions (p = 0.079).    
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Figure 16.  Mean electrolyte excretion levels of estimated 24HU Na+, K+ and SU Cl- for 











This study analyzed urinary excretion levels of Na+, K+ and Cl- in a hypertensive 
population from the Kasigau region of western Kenya.  After analyzing the cohort, we 
conclude that the overall study population does not show a strong positive correlation 
between systolic BP and Na+ consumption.  While salt consumption may not be the 
primary mechanism driving hypertension in this population, it still likely influences this 
multifactorial disease, since within the population there are clear trends between Na+ 
excretion levels and increasing age, BMI, and hypertension states.   
Aging is one of the main non-modifiable risk factors that progressively lowers 
physiological functions of all organ systems (Buford 2016; Franceschi et al., 2008).  In 
our study, increasing age groups had increasing systolic BP but did not show a significant 
correlation with Na+ and K+ excretion as expected.  Age related hypertension is a result 
of vascular changes over time (Park et al., 2015).  Increased systolic BP in the elderly is 
associated with arterial stiffening that is a result of elastic fiber degradation and vascular 
fibrosis (Park & Lakatta, 2012).  Arterial stiffening happens naturally over time, 
however, it can be accelerated when other risk factors are in play, such as obesity, high 
salt intake, diabetes, activation of RAS and oxidative stress.  With the aging population 
worldwide it is important to address modifiable risk factors in order to reduce the 
prevalence of hypertension. 
Recent studies have shown that oxidative stress and inflammation can lead to 
hypertension (Park and Lakatta, 2012; Rodrigo et al., 2011; Vaziri and Rodriguez-Iturbe, 
46 
 
2006; Vaziri, 2008) via activation of NADPH oxidase activity and reduction of nitric 
oxide (NO) availability (Park and Lakatta, 2012; Rodrigo et al., 2011).  NADPH oxidase 
is stimulated by several hormones: endothelin-1 (ET-1), urotensin and Ang-II (Rodrigo et 
al., 2011).  Ang-II, a vasoconstrictor of the RAS, upregulates NADPH oxidase which in 
turn increases ROS causing oxidative stress as a result of imbalanced antioxidants and 
ROS (Rodrigo et al., 2011).  In this way, inflammation stimulates oxidative stress, which 
partly stimulates inflammation through redox-sensitive effectors leading to a “vicious 
cycle” ultimately resulting in endothelial dysfunction (Figure 17).  Investigating RAS, 
oxidative stress, and inflammatory markers will be an important next step in evaluating 
the mechanism of hypertension in our study population.    
   
Figure 17.  Cycle of aging, inflammation, and oxidative stress in relationship to 




Additionally, oxidative stress can be caused by environmental factors such as air 
pollution and particulate matter (PM).  According to the WHO (2012), up to 8 million 
people die every year due to exposure to air pollution, the largest environmental risk 
factor on a global scale.  About fifty percent of the deaths that occur are attributed to 
indoor or household air pollution (HAP) caused by heating and cooking using solid fuels 
like coal, wood or biomass waste (WHO, 2014a).  Open fire stoves are widely used in 
LMICs with the majority (~90 %) used in rural households without appropriate 
ventilation (Gordon et al., 2014, Kajdan et al., 2015).  Combustion of solid fuels releases 
carbon dioxide and PM, which can lead to pulmonary disease, cancer, CVD and high BP 
(Brook et al., 2010; Gordon et al., 2014; Majdan et al., 2015).  PM air pollutants can 
affect an individual’s BP directly and indirectly.  Indirect effects of PM include 
inflammation and oxidative stress responses, which cause an increase in BP (Brook et al., 
2010), and indirect effects of PM include low birthweight of babies due to PM exposure 
to pregnant women (Gordon et al., 2014).  Low birthweight is known to be inversely 
associated with BP (as cited in Intapad et al., 2014).  Hence, individuals who participated 
in our study might have been predisposed to high BP upon birth which is exacerbated by 
being exposed to PM throughout their lifetime.  Testing the exposure to carbon dioxide 
and PM in each participants household might provide an explanation for increased 
systolic BP in the population.   
As mentioned in the results section, urinary electrolyte excretion values show a 
positive trend with BMI, with the exception for underweight individuals (Figure 15).  
This could be considered a confirmation that overweight and obese individuals tend to 
consume more salt than normal weight individuals.  Larger caloric intake and food higher 
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in salt concentration along with an unbalanced diet overall, is a risk for hypertension.  A 
study by Kaduta et al. (2011) demonstrated a link between education level, 
socioeconomic status and obesity.  People living in rural areas follow diets less due to an 
unbiased self-image, than those living in urban areas.  Less variance in available food 
also contributes to a simple diet, and indeed previous work from our lab has shown an 
inverse correlation between income and health in the villages of Kasigau (Williams, 
2012). 
This study also showed that there is a significant difference in BMI between 
women and men (25.9 kg/cm2 vs. 22.6 kg/cm2 respectively) which is similar to other 
reports from sub-Saharan African countries in which higher BMI in women is associated 
with a higher prevalence of hypertension and CVDs (BeLue et al., 2009).  Obesity in 
women is considered to also be a cause of a high prevalence of metabolic syndrome, 
which is linked to lack of education, changes in hormonal secretion due to aging, and low 
socio-economic status (Kaduka et al., 2012; Mugo, 2016).  Women living in rural areas 
tend to consume more carbohydrates compared to women in urban areas due to limited 
resources, leading to higher caloric intake and obesity among women in rural areas 
(Mugo, 2016; Steyn et al., 2012).   
Since this study takes place in rural Kenya, it is important to also consider how 
social-behavioral factors may be impacting hypertension.  Ethnic black women whose 
BMI is over 25kg/cm2 do not consider themselves overweight (Kruger et al., 2005; 
Malaza et al., 2012).  Women who are underweight or normal weight are often looked 
down upon in countries, where HIV prevalence is high, because thinness can be 
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associated with the disease (Kruger et al., 2005; Malaza et al., 2012).  Malaza et al. 
(2012) demonstrated that obesity is significantly higher in HIV-uninfected individuals 
when compared to HIV-infected.  Additionally, HIV-uninfected women have 
significantly more hypertension when compared to HIV-infected women.  In many sub-
Saharan countries overweight and obese women are considered to be attractive, 
successful and are treated with respect, a perspective that is encouraging both obesity and 
hypertension.   
Urine analysis of our population revealed a very high overall Na+/K+ ratio (1.57 ± 
1.12).  According to WHO guidelines, the recommended adult Na+ and K+ intake per day 
is 2.0 g and 3.5 g respectively (Na+/K+ ratio of ~0.55) (WHO, 2012a; WHO, 2012b).  
However, the current global Na+ consumption is estimated to be more than double the 
recommended value, thus the reduction of salt intake and increase in K+, would greatly 
reduce the risk of CVD (WHO, 2012a; WHO, 2012b).  While our analysis of electrolyte 
excretion and systolic BP did not show a strong correlation between dietary Na+ intake, 
our study cohort does have a high Na+ intake overall (3.92 ± 2.1 g/day).  While greater 
than WHO recommended guidelines, global analysis of Na+/K+ ratios from ~100,000 
individuals from 18 countries revealed that only ~10% of individuals consume less than 
3.0 g of Na+ per day (Mente et al., 2014; WHO, 2012b).  Among people who consumed 
both >5 g of Na+ and <1.9 g of K+ per day, systolic BP can increase as high as 12 mmHg 
for each 1g increment of Na+ excretion (Mente et al., 2014).  A lower consumption of 
Na+ (3 – 5 g/day and < 3 g/day) was correlated with lower systolic BP increment (1.74 
mmHg per gram and 0.74 mmHg per gram, respectively).  A short term study by The 
Dietary Approaches to Stop Hypertension (DASH) showed that reducing Na+ intake from 
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3.5 to 2.5 g per day can reduce systolic BP by 2.1 mmHg (Sacks et al., 2001).  Analysis 
of ~100,000 people from 17 countries showed an association between high K+ excretion 
and reduced risk of CVD and mortality (O’Donnell et al., 2014).  Both of the before 
mentioned studies support the fact that electrolyte consumption can influence BP.  It 
should be noted that even though this Kenyan cohort appears to excrete Na+ and K+ 
values within normal ranges, we did not measure creatinine levels in the urinary samples.  
Normalizing our data to creatinine could provide a more accurate estimation of 24 h salt 
intake and possibly alter the given conclusions.   
Based on the data provided we conclude that people living in Kasigau do not 
consume large quantities of dietary Na+.  However, determining whether or not the 
population is salt-sensitive cannot be concluded at this point.  Nevertheless, education on 
salt consumption and low Na+ diet trials could be conducted in order to confirm that salt 
consumption is a modifiable risk factor.  Additionally expanding this study to look at the 
role of HAP and oxidative stress-linked hypertension is a logical next step.  Having 
another cohort in Kenya, from an urban area, would also be beneficial in comparing the 
trends and risk factors identified in this study.  Finally, in our study population ~57% of 
individuals have high prevalence of hypertension, however a study by Hendriks et al. 
(2012) indicates that a majority (83%) of people in Kenya are unaware of their disease.  
Thus, continuity of the PiC:MiK program is essential for increasing awareness of 
hypertension as well as other NCDs in the community.  The relationship with local 
physicians and community members who help the program and research will help the 
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APPENDIX C: Urine Collection Instructions (English) 
  
 
How to Provide a Clean Catch Urine Sample 
Instructions 
1. 1. Wash hands with soap and water, rinse, and dry or use a provided towelette. 
2. 2. Clean. Wipe the genitalia area with the provided antiseptic towellette. 
3. 3. Void. Pass the first portion of urine into the toilet, then pass a portion of 
remaining urine into the specimen cup. The cup should be help to avoid contact 
with any skin and clothing. Keep the fingers away from the rim and inner surface of 
the container. 
4. 4. Transfer. When voiding is completed, use provided pipette to transfer the 
continent into the designated Falcon tube, close the tube, and put the tube in the 












Tafadhali nawa mikono yako vizuri kwa kutumia sabuni na maji uliyopewa. Safisha 
vizuri alafu kausha mikono kwa kutumia kitambaa maalum ulichopewa. 
 
2. KUSAFISHA. 
Tafadhali safisha kwa makini sehemu yako ya siri ya kutoa mikojo kwa kutumia 
kifutio maalumu ulichopewa. 
 
3. KUKOJOA 
Kojoa mikojo ya kwanza ndani ya choo alafu weka kiwango kidogo cha mikojo ya 
mwisho ndani ya chupa uliyopewa. Tafadhali uhakikishe kuwa chupa hiyo 
haitashikana na ngozi ya mwili wako au nguo ulizovaa. Chunga usiguse ncha ya 
chupa au ndani ya chupa kwa kutumia vidole vyako. 
 
4. UHAMISHO 
Tafadhali tumia mrinja wa kuvutia mkojo uliopewa, kuvuta mkojo kutoka kwa 
chupa iliyobeba sampuli na kuuweka mkojo huo ndani ya chupa ya pili uliyopewa. 






24HU 24 hour urine 
ACE Angiotensin converting enzyme 
AGT  Angiotensinogen 
Ang-I Angiotensin I 
Ang-II Angiotensin II 
BMI Body mass index 
BP Blood pressure 
CVD Cardiovascular diseases 
DASH Dietary Approaches to Stop Hypertension 
ET-1 Endothelin-1 
GNI Gross National Income 
HAP Household air pollution 
HIV Human immunodeficiency virus 
LMIC Low- and middle-income countries 
NCD Non-communicable diseases 
NF-kB nuclear transcription factor kappa B 
NO Nitric Oxide 
PiC:MiK Partners in Caring: Medicine in Kenya 
PM Particulate matter 
RAS Renin-angiotensin system 
ROS Reactive oxygen species 
SU Spot urine 
WHO World Health Organization 
 
 
